Clinical Trial Update: Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating atorvastatin for progression of aortic dilatation and valvular degeneration in bicuspid aortic valve patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bicuspid Aortic Valve Disease

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Bicuspid Aortic Valve | Phase 3 | Status: COMPLETED